Sutent conditionally approved in EU
|Posted by Julie Royster (jroyster) on Jan 06 2009|
|GIST In the News >>|
Pending review of additional data to be submitted in August, the European Commission has granted conditional approval of Sutent for use against GIST and renal cell carcinoma within the European Union. You can link to read a news release.
Last changed: Jan 06 2009 at 11:29 AMBack